The Trump administration's decision to pause enforcement of an anti-bribery law raised the specter that drugmakers could ...
14h
Discover key insights from West Pharmaceutical Services' Q4 2024 earnings call, highlighting growth in GLP-1 elastomers, biologics, and HVP components.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback